新經濟股撐恆指續漲近300點 騰訊及友邦反覆升逾1%
恆指繼5月份累升1.5%成功打破「五窮咒」後,今天在新經濟股支撐午後升幅曾擴至296點,高見29,447創逾兩個月高,現造29,433,續升283點或1%,成交額1,316億元。
藍籌股榮辱互見,績後獲大行維持正面評級昨天股價飆11%美團(03690.HK)高見315.2元,現造312.2元,續升6.2%;重磅股騰訊(00700.HK)也反覆高見632元,現造629元,反覆續升1.6%。阿里巴巴(09988.HK)重越20天線(211.93元),最高見219.6元,現造219元,續升3.8%;舜宇(02382.HK)繼昨天稍作整固後,今天高見211元,創逾三個月高,現造207.2元,回升5%。
濠賭股金沙(01928.HK)、銀娛(00027.HK)、貼價走高的「三桶油」中石化(00386.HK)、中石油(00857.HK)及中海油(00883.HK)也升逾1.5%-3.5%,後者最強報8.73元,股價重越10天及20天線(8.6元)。此外,友邦(01299.HK)續跌至97.65元獲承接,掉頭回升1.3%,報100.5元,為表現最強金融股。
藥明生物(02269.HK)高見125.3元,現造124.6元,續升2.7%;但中生製藥(01177.HK)回吐2%報8.57元,正考驗牛熊線(8.45元);石藥(01093.HK)也由近三年高位吐逾0.5%報12.1元。
內需股恆安(01044.HK)、蒙牛(02319.HK)及申洲(02313.HK)依次跌1.5%-4%,後者由上市高位連跌第三天,股價失守10天線(197元),曾低見188.9元。此外,長實集團(01113.HK)由逾16個月高位連吐第二天兼略失10天及20天線(49.8元),報49.75元,續吐3.2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.